GSK and the University of Oxford have entered a new research partnership to launch an immuno-prevention programme to explore the potential of cancer prevention through vaccination. The partnership ...

Pharmaceutical giant GSK and the University of Oxford are creating a new cancer vaccine to prevent the disease from developing. The partnership intends to create a vaccine or vaccines which target ...

British pharma giant GSK is heading back to school, pledging up to 50 million pounds sterling (about $62.4 million) to work with the University of Oxford on ... up to launch a new molecular ...

GSK has teamed up ... it could also lead to new targeted cancer medicines, according to the partners. The programme will be led by Professor Sarah Blagden in Oxford's Department of Oncology ...

Pharmaceutical giant GSK has inked a deal with the University of Oxford that will see it pump tens of millions of pounds into research for cancer vaccines. The FTSE 100 firm said under a ...

GSK will invest up to £50 million in the new project, which could inform future development of cancer vaccines. The University of Oxford and GSK are to work on a vaccine to target cells in the ...